Connor, Clark & Lunn Investment Management (CC&L)’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3M | Buy |
|
|||||
|
2025
Q1 | $79.4M | Buy |
|
|||||
|
2024
Q4 | $52.5M | Buy |
|
|||||
|
2024
Q3 | $50.7M | Buy |
|
|||||
|
2024
Q2 | $12.4M | Buy |
|
|||||
|
2024
Q1 | $10.3M | Buy |
|
|||||
|
2023
Q4 | $6.02M | Buy |
|
|||||
|
2023
Q3 | $449K | Sell |
|
|||||
|
2023
Q2 | $3M | Sell |
|
|||||
|
2023
Q1 | $6.94M | Sell |
|
|||||
|
2022
Q4 | $11.2M | Buy |
|
|||||
|
2022
Q3 | $3.51M | Buy |
|
|||||
|
2022
Q2 | $1.23M | Buy |
|
|||||
|
2022
Q1 | $875K | Buy |
|
|||||
|
2021
Q4 | $335K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.02M | Buy |
|